2017
DOI: 10.1007/s11030-017-9790-3
|View full text |Cite
|
Sign up to set email alerts
|

Solvent-free synthesis and anticancer activity evaluation of benzimidazole and perimidine derivatives

Abstract: Benzimidazoles and perimidines are subsidiary structures for research and development of new biologically active molecules and have established prominence because of their promising biological activities. Two series of diversified heterocyclic molecules, tetracyclic benzimidazole derivatives, tetracyclic and pentacyclic perimidine derivatives have been synthesized in good yields by condensation of acid anhydrides and diacids with various diamines using microwave irradiation. All synthesized derivatives were fu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 34 publications
1
15
0
Order By: Relevance
“…Triazole containing 4,5,6,7-tetrabromo-1 H -benzimidazole derivatives 258–259 bearing carboxyl substituent manifested the most prominent inhibitory effect against protein kinase 2 (CK2) with binding affinity value in the range of 1.96–0.91 µM ( Chojnacki et al, 2017 ). Compounds 260–264 exerted antiproliferative property in MTT assay against five human cancer cell lines, breast (T47D), lung (NCl H-522), liver (HepG2), colon (HCT-15) and ovary (PA-1) with IC 50 (mean ± SD) value of 7.5 ± 0.3 to 14.6 ± 0.4 μM ( Kumar et al, 2018 ). Upon assessment of antiproliferative property against four cancer cell lines (HeLa, MCF-7, A549 and DU-145 alongside normal HEK-293 cell line), Baig et al ( Baig et al, 2018 ) enumerated noteworthy IC 50 (1.08 µM) of derivative 265 against A549 cell line.…”
Section: Biological Activitiesmentioning
confidence: 99%
“…Triazole containing 4,5,6,7-tetrabromo-1 H -benzimidazole derivatives 258–259 bearing carboxyl substituent manifested the most prominent inhibitory effect against protein kinase 2 (CK2) with binding affinity value in the range of 1.96–0.91 µM ( Chojnacki et al, 2017 ). Compounds 260–264 exerted antiproliferative property in MTT assay against five human cancer cell lines, breast (T47D), lung (NCl H-522), liver (HepG2), colon (HCT-15) and ovary (PA-1) with IC 50 (mean ± SD) value of 7.5 ± 0.3 to 14.6 ± 0.4 μM ( Kumar et al, 2018 ). Upon assessment of antiproliferative property against four cancer cell lines (HeLa, MCF-7, A549 and DU-145 alongside normal HEK-293 cell line), Baig et al ( Baig et al, 2018 ) enumerated noteworthy IC 50 (1.08 µM) of derivative 265 against A549 cell line.…”
Section: Biological Activitiesmentioning
confidence: 99%
“…A. Kumar et al [63] synthesized an array of 1 H ‐benzimidazole tetracyclic derivatives by microwave irradiation method. The synthesized compounds were screened for their antiproliferative activities against T47D (breast), NCl H‐522 (lung), HCT‐15 (colon), PA‐1 (ovary), and Hep G2 (liver) human cancer cell lines by MTT assay.…”
Section: Benzimidazole As Target Oriented Anticancer Agentsmentioning
confidence: 99%
“…Among all the tested compounds, 15a, 15b, and 16 revealed high antimicrobial activity against standard drugs (Scheme 14). Kumar et al [135] designed tetracyclic and pentacyclic perimidines from NDA and dicarbonyl compounds using microwave techniques and further evaluated their ability to suppress the growth of cancer cell lines. The in vitro antiproliferative activity was studied against five human cancer cell lines (breast T47D, lung NCl H-522, liver HepG2, colon HCT-15, ovary PA-1) using the MTT assay at 10 μM concentration.…”
Section: Biologic Applicationsmentioning
confidence: 99%